skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
The clinical findings of Botulinum Toxin manufactured by Daewoong have been published on international journal regarding the comparison with Botox
Date 2019-04-12 Hit 706
News List
Prev Daewoong Pharmaceutical hosts a symposium for the 20th anniversary of release of Albis.
Next Daewoong Pharmaceutical has released ‘Olomax’ for both hypertension and hyperlipidemia